Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation

被引:59
作者
Morrison, AM
Nutt, SL
Thevenin, C
Rolink, A
Busslinger, M
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Basel Inst Immunol, CH-4005 Basel, Switzerland
关键词
BSAP; Pax-5; pro-B cell development; IgH rearrangement; non-Hodgkin lymphoma; IgH-PAX5; translocation;
D O I
10.1006/smim.1998.0115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pax-5 codes for the transcription factor BSAP which is expressed throughout B cell development except in terminally differentiated plasma cells. Gene targeting experiments in the mouse revealed a differential dependency of fetal and adult B-lymphopoiesis on this transcription factor. BSAP is required for B-lineage commitment in the fetal liver and for progression beyond an early pro-B cell stage in adult bone marrow. The characterization of Pax-5-deficient pro-B cells demonstrated an important role of BSAP in the regulation of the CD19, mb-1 (Ig alpha) and N-myc genes as well as in the developmental pathway controlling V(H-)to-D(H)J(H) recombination at the immunoglobulin heavy-chain (IgH) locus. The human PAX-5 gene was recently shown to participate together with the Ig-H locus in the chromosomal translocation t(9;14)(p13;q32). This translocation is characteristic of a small subset of non-Hodgkin lymphomas exhibiting plasmacytoid differentiation. The translocated PAX-5 gene is deregulated by the insertion of IgH regulatory elements into its 5' region, which may contribute to tumorigenesis by interfering with the shut-down of PAX-5 transcription and thus with the completion of plasma cell differentiation.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 74 条
  • [1] PAX-5 ENCODES THE TRANSCRIPTION FACTOR BSAP AND IS EXPRESSED IN LYMPHOCYTES-B, THE DEVELOPING CNS, AND ADULT TESTIS
    ADAMS, B
    DORFLER, P
    AGUZZI, A
    KOZMIK, Z
    URBANEK, P
    MAURERFOGY, I
    BUSSLINGER, M
    [J]. GENES & DEVELOPMENT, 1992, 6 (09) : 1589 - 1607
  • [2] Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5
    Andersson, T
    Neurath, MF
    Grant, PA
    Pettersson, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) : 2499 - 2507
  • [3] APEL TW, 1992, ONCOGENE, V7, P1267
  • [4] E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS
    BAIN, G
    MAANDAG, ECR
    IZON, DJ
    AMSEN, D
    KRUISBEEK, AM
    WEINTRAUB, BC
    KROP, I
    SCHLISSEL, MS
    FEENEY, AJ
    VANROON, M
    VANDERVALK, M
    TERIELE, HPJ
    BERNS, A
    MURRE, C
    [J]. CELL, 1994, 79 (05) : 885 - 892
  • [5] A NOVEL B-CELL LINEAGE-SPECIFIC TRANSCRIPTION FACTOR PRESENT AT EARLY BUT NOT LATE STAGES OF DIFFERENTIATION
    BARBERIS, A
    WIDENHORN, K
    VITELLI, L
    BUSSLINGER, M
    [J]. GENES & DEVELOPMENT, 1990, 4 (05) : 849 - 859
  • [6] CONSERVATION OF A LARGE PROTEIN DOMAIN IN THE SEGMENTATION GENE PAIRED AND IN FUNCTIONALLY RELATED GENES OF DROSOPHILA
    BOPP, D
    BURRI, M
    BAUMGARTNER, S
    FRIGERIO, G
    NOLL, M
    [J]. CELL, 1986, 47 (06) : 1033 - 1040
  • [7] BORN W, 1988, J IMMUNOL, V140, P3228
  • [8] Composition and function of T-cell receptor and B-cell receptor complexes an precursor lymphocytes
    Borst, J
    Jacobs, H
    Brouns, G
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (02) : 181 - 190
  • [9] Deregulation of PAX-5 by translocation of the E mu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma
    Busslinger, M
    Klix, N
    Pfeffer, P
    Graninger, PG
    Kozmik, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 6129 - 6134
  • [10] THE ROLE OF BSAP (PAX-5) IN B-CELL DEVELOPMENT
    BUSSLINGER, M
    URBANEK, P
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (05) : 595 - 601